Lv5
910 积分 2024-09-24 加入
What Happens in Successful Optimizations? A Survey of 2018–2024 Literature
1天前
已完结
Discovery of Clinical Candidate IAG933, a Potent YAP-TEAD PPI Disrupter
1天前
已完结
Copper promoted C-S and C-N cross-coupling Reactions:The synthesis of 2-(N-Aryolamino)benzothiazoles and 2-(N-Aryolamino)benzimidazoles
6天前
已完结
Abstract PS4-04-30: Discovery of NKT5097: a first-in-class, highly potent and selective, orally bioavailable CDK2/4 dual degrader for cancer therapy
6天前
已关闭
Discovery of BMS-986458, a Potent and Selective B-Cell Lymphoma 6 Protein Ligand-Directed Degrader, for the Treatment of B-Cell Non-Hodgkin Lymphoma
26天前
已完结
Arylidene-Thiazoldione Scaffold Acts as the E3 Ligand of DCAF11 for PROTAC Design
1个月前
已完结
Design, Synthesis, and Evaluation of Nucleolin-Bridged, MDM2-Recruiting IRAK4 Degraders for the Treatment of Autoimmune Diseases
1个月前
已完结
Natural Product–Inspired PROTACs for Leukemia Therapy: Hederagenin-Driven Targeted Degradation of SKP2
1个月前
已完结
Discovery of Monovalent Direct Degraders of BRD4 that Act via the Recruitment of DCAF11
2个月前
已完结
Discovery of a DCAF11-dependent cyanoacrylamide-containing covalent degrader of BET-proteins
2个月前
已完结
皖公网安备34019202002308
